BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3265677)

  • 21. Purification and characterization of human fibroblast-derived hybridoma growth factor identical to T-cell-derived B-cell stimulatory factor-2 (interleukin-6).
    Van Damme J; Cayphas S; Van Snick J; Conings R; Put W; Lenaerts JP; Simpson RJ; Billiau A
    Eur J Biochem; 1987 Nov; 168(3):543-50. PubMed ID: 3499318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The production and characteristics of an interleukin-6-dependent hybridoma].
    Kliushnenkova EN; Malaĭtseva VV
    Biull Eksp Biol Med; 1992 Jul; 114(8):179-81. PubMed ID: 1467486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells.
    Coulie PG; Vanhecke A; Van Damme J; Cayphas S; Poupart P; De Wit L; Content J
    Eur J Immunol; 1987 Oct; 17(10):1435-40. PubMed ID: 3500055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
    Chen Q; DeFrances MC; Zarnegar R
    Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism between interferon-gamma and cAMP in induction of hepatocyte growth factor in human skin fibroblasts.
    Gohda E; Kuromitsu K; Matsunaga T; Miyazaki M; Yamamoto I
    Cytokine; 2000 Jun; 12(6):780-5. PubMed ID: 10843764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline in growth and antibody production of established hybridomas and transfectomas with addition of interleukin 6.
    Karavodin LM; Glasebrook AL; Phelps JL
    Eur J Immunol; 1989 Jul; 19(7):1351-4. PubMed ID: 2788095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts.
    Brauchle M; Angermeyer K; Hübner G; Werner S
    Oncogene; 1994 Nov; 9(11):3199-204. PubMed ID: 7936642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells.
    Yokomuro S; Tsuji H; Lunz JG; Sakamoto T; Ezure T; Murase N; Demetris AJ
    Hepatology; 2000 Jul; 32(1):26-35. PubMed ID: 10869285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
    Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma.
    Tiggelman AM; Boers W; Linthorst C; Sala M; Chamuleau RA
    J Hepatol; 1995 Sep; 23(3):307-17. PubMed ID: 8550995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
    Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G
    Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    Clin Exp Immunol; 2005 Nov; 142(2):285-91. PubMed ID: 16232215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feline hybridoma growth factor/interleukin-6 activity.
    Ohashi T; Goitsuka R; Ono K; Hasegawa A
    J Leukoc Biol; 1989 Dec; 46(6):501-7. PubMed ID: 2681491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
    Zlotnik A; Fischer M; Roehm N; Zipori D
    J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes.
    Guillén MI; Gómez-Lechón MJ; Nakamura T; Castell JV
    Hepatology; 1996 Jun; 23(6):1345-52. PubMed ID: 8675150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha.
    Tiggelman AM; Boers W; Linthorst C; Brand HS; Sala M; Chamuleau RA
    J Hepatol; 1995 Sep; 23(3):295-306. PubMed ID: 8550994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta stimulates interleukin-11 production by human periodontal ligament and gingival fibroblasts.
    Yashiro R; Nagasawa T; Kiji M; Hormdee D; Kobayashi H; Koshy G; Nitta H; Ishikawa I
    J Clin Periodontol; 2006 Mar; 33(3):165-71. PubMed ID: 16489941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL; Ponzio NM; Thorbecke GJ
    J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.